85.5
PharmaCyte Biotech, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
Assets
(positive)
Change from FY22 to FY26
millions USD
FY22:
FY23:
68.1
FY24:
50.4
FY25:
22.4
FY26:
37.4
(positive)
Change from FY22 to FY26
millions USD
FY22:
5.13
FY23:
5.13
FY24:
9.46
FY25:
32.8
FY26:
9.33
Total assets
Change from FY22 to FY26
millions USD
FY22:
90.6
FY23:
73.3
FY24:
59.9
FY25:
55.2
FY26:
46.8
Liabilities & Equity
(negative)
Change from FY22 to FY26
millions USD
FY22:
0.70
FY23:
0.59
FY24:
7.42
FY25:
2.91
FY26:
0.83
(negative)
millions USD
FY22:
0
FY23:
0
FY24:
13.0
FY25:
0.36
FY26:
10.9
(positive)
Change from FY22 to FY26
millions USD
FY22:
89.9
FY23:
72.7
FY24:
27.6
FY25:
51.9
FY26:
33.3
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY22:
90.6
FY23:
73.3
FY24:
–
FY25:
55.2
FY26:
–
All amounts in millions USD